Skip to main content

Table 4 The risk factors for chemotherapy-associated lymphopenia <0.66 × 10 9 /L in colorectal cancer by multivariate logistic regression model

From: The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer

Variables Odds ratio 95% confidence intervals P-value
Pretreatment albumin    
≥35 g/L 1.00(ref.)   
<35 g/L 0.685 0.302-1.550 0.363
Pretreatment CEA a    
<10 ng ml-1 1.00(ref.)   
≥10 ng ml-1 3.338 1.523-7.315 0.003
Differentiation    
Well 1.00(ref.)   
Moderately 1.200 0.308-4.678 0.793
Low 3.049 0.553-16.828 0.201
Sex    
Male 1.00(ref.)   
Female 1.219 0.600-2.474 0.584
Age    
≤49 years 1.00(ref.)   
50-60 yeas 0.840 0.271-2.608 0.763
>60 years 2.358 0.904-6.154 0.080
Location    
Rectum 1.00(ref.)   
Left colon cancer 1.056 0.484-2.300 0.892
Right colon cancer 0.532 0.192-1.475 0.225
Stage    
II 1.00(ref.)   
III 0.847 0.403-1.781 0.661
  1. a Carcinoembryonic antigen.